Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Max Meyrath
Observed names:
M. Meyrath,
Meyrath, Max,
Meyrath, Max Marc Roger
Institution:
Luxembourg Institute of Health
Observed institutions:
University of Liège,
University of Luxembourg,
Heidelberg University,
Luxembourg Institute of Health,
Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID:
0000-0001-8585-0474
Observed ORCID:
0000-0001-8585-0474
OpenAlex ID:
A5031901906
The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides
2020
·
Max Meyrath
, Martyna Szpakowska
, et al.
·
Nature Communications
·
152
PDF
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
2019
·
Elin Sjöberg
, Max Meyrath
, et al.
·
Clinical Cancer Research
·
135
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds
2019
·
Elise Wouters
, Jolien Walraed
, et al.
·
ACS Pharmacology & Translational Science
·
78
Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3
2017
·
Martyna Szpakowska
, Amanda M Nevins
, et al.
·
British Journal of Pharmacology
·
78
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture
2016
·
Christian Harak
, Max Meyrath
, et al.
·
Nature Microbiology
·
68
CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6
2021
·
Andy Chevigné
, Bassam Janji
, et al.
·
Cancers
·
56
PDF
Multiple Drugs Compete for Transport via the Plasmodium falciparum Chloroquine Resistance Transporter at Distinct but Interdependent Sites
2014
·
Sebastiano Bellanca
, Robert L. Summers
, et al.
·
Journal of Biological Chemistry
·
53
PDF
Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists
2018
·
Martyna Szpakowska
, Max Meyrath
, et al.
·
Biochemical Pharmacology
·
51
PDF
Proadrenomedullin N‑Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7
2021
·
Max Meyrath
, Christie B. Palmer
, et al.
·
ACS Pharmacology & Translational Science
·
40
PDF
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
2020
·
Ariadni Kouzeli
, Paul J. Collins
, et al.
·
Frontiers in Immunology
·
37
PDF
Atypical opioid receptors: unconventional biology and therapeutic opportunities
2021
·
Christie B. Palmer
, Max Meyrath
, et al.
·
Pharmacology & Therapeutics
·
36
PDF
The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy
2020
·
Elin Sjöberg
, Max Meyrath
, et al.
·
Advances in cancer research
·
33
Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22
2020
·
Max Meyrath
, Nathan Reynders
, et al.
·
Journal of Leukocyte Biology
·
31
The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7
2021
·
Martyna Szpakowska
, Ann M. Decker
, et al.
·
Signal Transduction and Targeted Therapy
·
30
PDF
The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B
2022
·
Giulia D’Uonnolo
, Nathan Reynders
, et al.
·
Frontiers in Immunology
·
26
Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors
2022
·
Rafael Luís
, Giulia D’Uonnolo
, et al.
·
Methods in cell biology
·
24
Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3
2024
·
Aurelien M. Zarca
, Ilze Adlere
, et al.
·
Molecular Pharmacology
·
16
PDF
Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)
2024
·
Olena Tsurkalenko
, Dmitry Bulaev
, et al.
·
BMC Infectious Diseases
·
16
PDF
Nanoluciferase-based complementation assay for systematic profiling of GPCR–GRK interactions
2022
·
Christie B. Palmer
, Giulia D'Uonnolo
, et al.
·
Methods in cell biology
·
12
Characterization of a Threonine-Rich Cluster in Hepatitis C Virus Nonstructural Protein 5A and Its Contribution to Hyperphosphorylation
2018
·
Christian Schenk
, Max Meyrath
, et al.
·
Journal of Virology
·
9
The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein–protein interaction in glioblastoma
2019
·
Virginie Neirinckx
, Ann-Christin Hau
, et al.
·
Neuro-Oncology Advances
·
8
PDF
ACKR5/GPR182 is a scavenger receptor for the atypical chemokine CXCL17, GPR15L and various endogenous peptides
2024
·
Max Meyrath
, Christie B. Palmer
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
7
PDF
Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples
2022
·
Max Meyrath
, Martyna Szpakowska
, et al.
·
Methods in enzymology on CD-ROM/Methods in enzymology
·
7
PDF
Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840
2025
·
Reggie Bosma
, Desislava Nesheva
, et al.
·
Molecular Pharmacology
·
6
Atypical activation and molecular glue-like dimerization mechanism of an intrinsically-biased chemokine receptor
2025
·
Nilanjana Banerjee
, Manisankar Ganguly
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
4
PDF
Show more works
View as search
Works count:
49
Citation count:
1,021
H-index:
16
I10-index:
19
Year
Topic
Type